Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RECLAST vs REGORAFENIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RECLAST vs REGORAFENIB: Safety Overview

Metric RECLAST REGORAFENIB
Total FAERS Reports 102 9,441
Deaths Reported 4 1,869
Death Rate 3.9% 19.8%
Hospitalizations 32 3,363
Average Patient Age 70.2 yrs 62.2 yrs
% Female Patients N/A 39.9%
FDA Approval Date N/A Jan 13, 2025
Manufacturer N/A Bayer HealthCare Pharmaceuticals Inc.
Route N/A ORAL
Marketing Status N/A Prescription